Dr. Bruce McManus has had a major hand in building excellence in heart and lung health sciences and medicine in Canada and B.C. for nearly three decades.

A versatile, magnetic leader of several units throughout the B.C. health sciences community, Dr. McManus has recruited and developed many outstanding faculty and trainees. He is known as an exceptional force for collaborative initiatives.

Dr. McManus leads the Centre of Excellence for Prevention of Organ Failure [PROOF], hosted by Providence Health Care and the University of British Columbia) and is the co-director of the Institute for Heart + Lung Health, a hub for research, clinical care and education.

His teams of scientists, physicians, economists and entrepreneurs are developing blood tests to improve the care of patients with failing vital organs.

Previously, Dr. McManus was the first scientific director of the Institute of Circulatory and Respiratory Health at the Canadian Institutes of Health Research where he led the creation of a national strategic research policy.

Dr. McManus is among the top scientists globally who focuses on solving viral heart disease mechanisms. He served on the executive of the landmark National Institutes of Health-funded therapeutic trial for viral heart disease (myocarditis).

For more than 30 years he has pursued unique work that has directly impacted lipid-lowering therapy for heart transplant patients.  His pioneering work on heart transplant immune rejection and rejection biomarkers led to the Grand Prize in Translational Medicine at the Bio-IT World Congress in 2010.